← Eichor
Condition: Young Adult Cancer Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Young Adult Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Romiplostim N01 for Chemotherapy-Induced Thrombocytopenia in Pediatric Cancer Patients
Phase 2 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT07043894
Efficacy of Laser Interstitial Thermal Therapy in Young Persons With Low-grade Glioma
NA · 1 location(s) · University of California, San Francisco · NCT07506239
Improving Health Insurance Literacy Among Young Adult Cancer Survivors
NA · 2 location(s) · University of Utah · NCT05829070
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumo
Phase 1/Phase 2 · 71 location(s) · Merck Sharp & Dohme LLC · NCT06395103
A Biobehavioral Intervention for Latino/Hispanic Young Adults with Cancer
NA · 1 location(s) · University of California, Irvine · NCT06338475
Effectiveness of a Self-health Assessment Mobile Application in Young-to-midlife Adults in Hong Kong
NA · 1 location(s) · The University of Hong Kong · NCT07720245
Precision Medicine for L/GCMN and Melanoma 1
Phase N/A · 1 location(s) · Fundacion Clinic per a la Recerca Biomédica · NCT06608420
Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG
EARLY_Phase 1 · 1 location(s) · Children's Hospital of Philadelphia · NCT05555550
Identification of Risk Factors, Exposomics and Genetic Susceptibility of Melanoma in Children, Adolescents and Young Adu
Phase N/A · 6 location(s) · University Hospital Tuebingen · NCT06680323
Group Curriculum for Improving Survivorship Outcomes in Adolescent and Young Adult Cancer Survivors
NA · 1 location(s) · Mayo Clinic · NCT05584449
The Prospective Observational COMPRAYA Cohort Study
Phase N/A · 1 location(s) · The Netherlands Cancer Institute · NCT04682470
Securing Access to Innovative Molecules in Oncology and Hematology for Children, Adolescents and Young Adults
Phase N/A · 6 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT07727694
E-CANE: a National Program of Remote Health Education Workshops
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire de Nice · NCT06748820
Expressive Writing Program Among Young Adults With Blood Cancer
NA · 1 location(s) · Blood Cancer United · NCT07413991
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leu
Phase 3 · 460 location(s) · Alliance for Clinical Trials in Oncology · NCT03150693
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
Phase 3 · 205 location(s) · AstraZeneca · NCT06079671
DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With H
Phase 2/Phase 3 · 27 location(s) · Cancer Research UK · NCT05770102
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
Phase 1/Phase 2 · 1 location(s) · Memorial Sloan Kettering Cancer Center · NCT05004116
Systemic Biomarkers to Predict Radiation-Induced Neurocognitive Decline
Phase N/A · 1 location(s) · Tata Memorial Centre · NCT06779487
Acupuncture for People Experiencing Period Loss Due to Chemotherapy
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06915116
Outcomes of Health Care Transition for AYA With a Cancer Predisposition
Phase N/A · 1 location(s) · St. Jude Children's Research Hospital · NCT07456904
Writing Intervention With Adolescents and Young Adults With Cancer
NA · 1 location(s) · St. Jude Children's Research Hospital · NCT05975333
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Phase 3 · 205 location(s) · Children's Oncology Group · NCT06513962
Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma
Phase 1 · 16 location(s) · New York Medical College · NCT04972942
Investigating Memory and Physical Activity After Cancer Treatment in Survivors of Adolescent and Young Adult Cancers
Phase N/A · 1 location(s) · Mayo Clinic · NCT06880861
Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
Phase 4 · 5 location(s) · St. Jude Children's Research Hospital · NCT06289673
Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid Tumors
Phase 1 · 1 location(s) · Stanford University · NCT06500819
Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
Phase 2 · 5 location(s) · Children's Hospital of Philadelphia · NCT06458036
Brigatinib in Pediatric and Young Adult Patients With ALK+ ALCL, IMT or Other Solid Tumors
Phase 1/Phase 2 · 2 location(s) · Princess Maxima Center for Pediatric Oncology · NCT04925609
Navigation Intervention for Adolescent and Young Adult Cancer Survivors
NA · 1 location(s) · Kaiser Permanente · NCT07406087
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.